KEGG   DRUG: Axatilimab
Entry
D11952                      Drug                                   
Name
Axatilimab (USAN/INN);
Axatilimab-csfr;
Niktimvo (TN)
Product
Formula
C6568H10092N1696O2052S48
Exact mass
147092.4080
Mol weight
147183.74
Sequence
(Heavy chain)
EVTLKESGPA LVKPTQTLTL TCTFSGFSLT TYGMGVGWIR QPPGKALEWL ANIWWDDDKY
YNPSLKNRLT ISKDTSKNQV VLTMTNMDPV DTATYYCARI GPIKYPTAPY RYFDFWGQGT
MVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK
SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCLASEDIY DNLAWYQQKP GKAPKLLIYY ASSLQDGVPS
RFSGSGSGTD YTLTISSLQP EDFATYYCLQ DSEYPWTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H97, H140-L214, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'97, H'140-L'214, H'153-H'209, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Remark
Product: D11952<US>
Efficacy
Antineoplastic, Anti-macrophage colony-stimulating factor 1 receptor antibody
  Disease
Chronic graft-versus-host disease [DS:H00084]
  Type
Monoclonal antibody
Comment
Treatment of advanced solid tumors, dermatologic and fibrotic diseases
Target
CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
Brite
USP drug classification [BR:br08302]
 Immunological Agents
  Immunological Agents, Other
   Immunological Agents, Miscellaneous
    Axatilimab
     D11952  Axatilimab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    CSF1R (FMS, CD115)
     D11952  Axatilimab (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11952
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11952
Other DBs
CAS: 2155851-88-8
PubChem: 497620365
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system